Suppr超能文献

Silexan for treatment of anxiety and depression in the context of COVID-19.

作者信息

Bartova Lucie, Dold Markus, Fugger Gernot, Weidenauer Ana, Rujescu Dan, Kasper Siegfried

机构信息

Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.

Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria; Psychiatric Day Hospital, University Hospital St. Poelten, St. Poelten, Austria; Karl Landsteiner Private University of Health Sciences, Krems an der Donau, Austria.

出版信息

Eur Neuropsychopharmacol. 2023 May;70:47-48. doi: 10.1016/j.euroneuro.2023.02.015. Epub 2023 Feb 23.

Abstract
摘要

相似文献

1
Silexan for treatment of anxiety and depression in the context of COVID-19.西乐葆用于治疗新型冠状病毒肺炎相关的焦虑和抑郁。
Eur Neuropsychopharmacol. 2023 May;70:47-48. doi: 10.1016/j.euroneuro.2023.02.015. Epub 2023 Feb 23.
8
Silexan in anxiety disorders: Clinical data and pharmacological background.思乐康治疗焦虑障碍:临床数据和药理学背景。
World J Biol Psychiatry. 2018 Sep;19(6):412-420. doi: 10.1080/15622975.2017.1331046. Epub 2017 Jun 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验